Bioactive Properties of Tagetes erecta Edible Flowers: Polyphenol and Antioxidant Characterization and Therapeutic Activity against Ovarian Tumoral Cells and Caenorhabditis elegans Tauopathy
Metadatos
Afficher la notice complèteAuteur
Rivas García, Lorenzo; Crespo Antolín, Lara; Forbes Hernández, Tamara Yuliett; Romero Márquez, José Manuel; Navarro Hortal, María Dolores; Arredondo, Miguel; Llopis González, Juan; Quiles Morales, José Luis; Sánchez González, CristinaEditorial
MDPI
Materia
Cancer Tau protein Mitochondria
Date
2023-12-24Referencia bibliográfica
Rivas-García, L.; Crespo-Antolín, L.; Forbes-Hernández, T.Y.; Romero-Márquez, J.M.; Navarro-Hortal, M.D.; Arredondo, M.; Llopis, J.; Quiles, J.L.; Sánchez-González, C. Bioactive Properties of Tagetes erecta Edible Flowers: Polyphenol and Antioxidant Characterization and Therapeutic Activity against Ovarian Tumoral Cells and Caenorhabditis elegans Tauopathy. Int. J. Mol. Sci. 2024, 25, 280. https://doi.org/10.3390/ijms25010280
Patrocinador
FEDER/Junta de Andalucía-Consejería de Economía y Conocimiento, Grants BAGR-193-UGR18, B-AGR-652-UGR20, and P20_00336; Postdoctoral fellowship financed by Junta de Andalucia (ref. POSTDOC_21_028)Résumé
Tagetes erecta is an edible flower deeply rooted in traditional Mexican culture. It holds a
central role in the most popular and iconic Mexican celebration, “the Day of the Dead”. Furthermore,
it is currently receiving interest as a potential therapeutic agent, motivated mainly by its polyphenol
content. The present study aims to evaluate the biological activity of an extract synthesized from
the petals of the edible flower T. erecta. This extract showed significant antioxidant scores measured
by the most common in vitro methodologies (FRAP, ABTS, and DPPH), with values of 1475.3 μM
trolox/g extr, 1950.3 μM trolox/g extr, and 977.7 μM trolox/g extr, respectively. In addition, up to
36 individual polyphenols were identified by chromatography. Regarding the biomedical aspects
of the petal extract, it exhibited antitumoral activity against ovarian carcinoma cells evaluated by
the MTS assay, revealing a lower value of IC50 compared to other flower extracts. For example, the
extract from T. erecta reported an IC50 value half as low as an extract from Rosa × hybrida and six
times lower than another extract from Tulbaghia violacea. This antitumoral effect of T. erecta arises
from the induction of the apoptotic process; thus, incubating ovarian carcinoma cells with the petal
extract increased the rate of apoptotic cells measured by flow cytometry. Moreover, the extract also
demonstrated efficacy as a therapeutic agent against tauopathy, a feature of Alzheimer’s disease
(AD) in the Caenorhabditis elegans experimental model. Treating worms with the experimental extract
prevented disfunction in several motility parameters such as wavelength and swimming speed.
Furthermore, the T. erecta petal extract prevented the release of Reactive Oxygen Species (ROS),
which are associated with the progression of AD. Thus, treatment with the extract resulted in an
approximate 20% reduction in ROS production. These findings suggest that these petals could serve
as a suitable source of polyphenols for biomedical applications.